Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antiviral”

Showing 20 of 0 results

Large-scale testing (Phase 3)Ended earlyNCT01821625
What this trial is testing

Study of Quadruple Therapy With Eltrombopag for Chronic Hepatitis C

Who this might be right for
ThrombocytopeniaHepatitis C
University of Texas Southwestern Medical Center 7
Testing effectiveness (Phase 2)Study completedNCT00002240
What this trial is testing

Study of a New Protease Inhibitor, BMS-232632, in Combination With Other Anti-HIV Drugs

Who this might be right for
HIV Infections
Bristol-Myers Squibb
Not applicableStudy completedNCT00000840
What this trial is testing

A Multicenter, Exploratory Study to Evaluate the Effects of Antiretroviral Cessation on Plasma Associated HIV-1 RNA

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 70
Early research (Phase 1)Study completedNCT02116543
What this trial is testing

TD-6450 MAD Study in HCV Infected Subjects

Who this might be right for
Hepatitis CHCV
Theravance Biopharma 47
Post-approval studies (Phase 4)UnknownNCT00823550
What this trial is testing

Antiviral Therapy in Hepatitis B Virus (HBV)-Related Advanced Liver Disease Patients

Who this might be right for
Hepatitis B, Chronic
Yonsei University 462
Testing effectiveness (Phase 2)Study completedNCT06214052
What this trial is testing

VH4524184 Proof-of-Concept in Treatment-Naïve Adults Living With HIV-1

Who this might be right for
HIV Infections
ViiV Healthcare 22
Early research (Phase 1)Study completedNCT01856426
What this trial is testing

Proof of Concept Study for Safety and Efficacy of EDP239 in Hepatitis C Subjects

Who this might be right for
Hepatitis C
Enanta Pharmaceuticals, Inc 28
Testing effectiveness (Phase 2)Ended earlyNCT02971033
What this trial is testing

Ezetimibe as a Safe and Efficacious Treatment for Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C
VA Office of Research and Development 2
Early research (Phase 1)Study completedNCT02104843
What this trial is testing

Drug Interaction Between Daclatasvir/Asunaprevir/BMS-791325 and Rosuvastatin

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 18
Not applicableStudy completedNCT02525055
What this trial is testing

Characterisation of a New Wild-Type H3N2 Virus for the Human Viral Challenge Model

Who this might be right for
Influenza
Hvivo 46
Early research (Phase 1)Study completedNCT01928147
What this trial is testing

A Phase 1a/1b Study of PPI-383 in Healthy Adults and Hepatitis C Patients

Who this might be right for
Hepatitis C, Chronic
Presidio Pharmaceuticals, Inc. 114
Testing effectiveness (Phase 2)Study completedNCT00002152
What this trial is testing

WF 10 IV Solution in Patients With Advanced HIV Disease

Who this might be right for
HIV Infections
Oxo Chemie GmbH 60
Testing effectiveness (Phase 2)Study completedNCT00001087
What this trial is testing

The Effectiveness of Nelfinavir and Efavirenz, Used Alone or Together, Combined With Other Anti-HIV Drugs in Patients Who Have Taken Anti-HIV Drugs

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 300
Large-scale testing (Phase 3)Study completedNCT02829359
What this trial is testing

Effects of Antiviral Therapy on HBV Reactivation

Who this might be right for
Liver Cancer
Guangxi Medical University 200
Large-scale testing (Phase 3)Looking for participantsNCT07576868
What this trial is testing

CP-COV03 Compared With Placebo in Participants With Dengue (Part 1) and Dengue-like Illness (Part 2)

Who this might be right for
Dengue
Hyundai Bioscience Co., Ltd. 210
Early research (Phase 1)Study completedNCT01627717
What this trial is testing

The Effects of the Direct Acting Antiviral Agent Boceprevir on the Pharmacokinetics of Maraviroc in Healthy Volunteers

Who this might be right for
Healthy
Centre hospitalier de l'Université de Montréal (CHUM) 11
Testing effectiveness (Phase 2)Study completedNCT00594880
What this trial is testing

Antiviral Activity of Peg-IFN-Alpha-2A in Chronic HIV-1 Infection

Who this might be right for
HIV Infections
The Wistar Institute 23
Not applicableUnknownNCT02856243
What this trial is testing

Direct Antiviral Agents for Hepatitis C Virus-associated Cryoglobulinaemia Vasculitis

Who this might be right for
VasculitisCryoglobulinemiaHepatitis C
Assistance Publique - Hôpitaux de Paris 120
Post-approval studies (Phase 4)UnknownNCT05552950
What this trial is testing

The Efficacy and Safety of BioBlock® Intranasally Administered Virus-Neutralizing Bovine Colostrum Nasal Spray in Preventing of COVID-19 (Coronavirus Disease-19) Infection in Healthy Volunteer Individuals

Who this might be right for
SARS CoV 2 Infection
Chemi-Pharm AS 2,000
Not applicableStudy completedNCT03939013
What this trial is testing

Hepatitis C: Community Testing and Treatment (CT2 Study Myanmar)

Who this might be right for
Hepatitis C
Macfarlane Burnet Institute for Medical Research and Public Health Ltd 634
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation